🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchOrforglipron ATTAIN-4 — my results so far Page 7

Orforglipron ATTAIN-4 — my results so far

roxy_nash Sat, Jul 12, 2025 at 6:46 AM 43 replies 2,076 viewsPage 7 of 9
LipidDoc_ATL
Senior Member
1,123
5,678
Apr 2024
Atlanta, GA
Nov 9, 2025 at 1:45 AM#31

Adding the clinical framing, because it changes how the question reads. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.

21 19rachel_ABQ, traveltech_sara, AttorneyGrant and 18 others
Reply Quote Save Share Report
LabKate
Senior Member
2,678
11,234
Jan 2024
Oregon
Nov 18, 2025 at 6:25 PM#32
LipidDoc_ATL said:
The useful move here is to separate what is established from what is widely repeated.

Can confirm. Same sequence, different timescale.

22 20laura_annarbor, JenMemphis, pat_auckland and 19 others
Reply Quote Save Share Report
bri_stats
Member
789
3,456
May 2024
Seattle, WA
Nov 28, 2025 at 11:10 AM#33
LipidDoc_ATL said:
The useful move here is to separate what is established from what is widely repeated.

Adding the part of the answer the thread has not reached. Worth answering the question that was asked rather than the one behind it. The narrow version usually has an answer; the broad version usually does not, and answering the broad one is how a thread stops being useful.

23 21TomFromTexas, mike.trainer_LA, sarah_nash92 and 20 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
labquiet_amy
Senior Member
1,234
6,789
Mar 2024
Cambridge, MA
Dec 8, 2025 at 4:01 AM#34

One concrete data point for the thread. One practical note: write down what you did and when, before you need it. Reconstructing a timeline from memory three months later is how people end up unable to answer the one question that would have resolved it.

24 22bri_stats, pete_manc_UK, anna.melb_AU and 21 others
Reply Quote Save Share Report
wanda_boise
Member
412
1,890
Aug 2024
Boise, ID
Dec 17, 2025 at 8:58 PM#35

One thing that is still open after LipidDoc_ATL’s answer:

What would you measure differently if you were starting again?

Last edited: Dec 18, 2025 at 1:58 AM
25 23ben_calgary, patPC_UT, Dr.DermMIA and 22 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register